Literature DB >> 31280215

Additional Surgical Resection After Endoscopic Resection for Patients With High-risk T1 Colorectal Cancer.

Kenta Iguchi1, Hiroyuki Mushiake2, Toru Aoyama3, Hirokazu Suwa1, Norio Yukawa1, Mitsuyoshi Ota1, Yasushi Rino3, Chikara Kunisaki1, Itaru Endo4, Munetaka Masuda3.   

Abstract

BACKGROUND/AIM: The purpose of this study was to reveal the safety and efficacy of additional surgical resection (ASR) for high-risk T1 colorectal cancer (CRC) after endoscopic resection (ER). PATIENTS AND METHODS: We retrospectively analyzed 191 patients with high-risk T1 CRC after ER.
RESULTS: The ASR was performed in 176 (92.1%) patients and 15 (7.9%) rejected ASR. All patients that underwent ASR experienced R0 resection; laparoscopic surgery was performed in 159 (90.3%) patients. Clavien-Dindo complications ≥grade II occurred in 33 patients (18.8%). Anastomotic leakage (8.5%) and ileus (5.7%) were the most frequent complications. The anus function was preserved in all patients. Metastatic lymph node was detected in 21 (11.9%) patients. There were no deaths or relapses in patients with ASR. One patient without ASR (6.7%) had a lymph node recurrence.
CONCLUSION: ASR was safe and effective and is recommended for high-risk T1 CRC patients after ER. A satisfactory long-term outcome can be achieved. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Colorectal surgery; colorectal neoplasms; endoscopy

Year:  2019        PMID: 31280215      PMCID: PMC6689358          DOI: 10.21873/invivo.11596

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  5 in total

1.  Risk of recurrence after local resection of T1 rectal cancer: a meta-analysis with meta-regression.

Authors:  Nik Dekkers; Hao Dang; Jolein van der Kraan; Saskia le Cessie; Philip P Oldenburg; Jan W Schoones; Alexandra M J Langers; Monique E van Leerdam; Jeanin E van Hooft; Yara Backes; Katarina Levic; Alexander Meining; Giorgio M Saracco; Fabian A Holman; Koen C M J Peeters; Leon M G Moons; Pascal G Doornebosch; James C H Hardwick; Jurjen J Boonstra
Journal:  Surg Endosc       Date:  2022-06-30       Impact factor: 4.584

2.  Targeted Nursing Combined with Endoscopic Submucosal Injection of Carbon Nanoparticles in the Treatment of Colorectal Cancer.

Authors:  Libo Yin
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-31       Impact factor: 2.650

Review 3.  Surgical resection after endoscopic resection in patients with T1 colorectal cancer: a meta-analysis.

Authors:  Yuan Tian; Long Rong; Yongchen Ma
Journal:  Int J Colorectal Dis       Date:  2020-10-27       Impact factor: 2.571

4.  Prediction of lymph node metastasis in early colorectal cancer based on histologic images by artificial intelligence.

Authors:  Manabu Takamatsu; Noriko Yamamoto; Hiroshi Kawachi; Kaoru Nakano; Shoichi Saito; Yosuke Fukunaga; Kengo Takeuchi
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.379

5.  En bloc right hemicolectomy with pancreatoduodenectomy for right-sided colon cancer invading duodenum.

Authors:  Xiao-Luan Yan; Kun Wang; Quan Bao; Hong-Wei Wang; Ke-Min Jin; Jun-Yun Wang; Bao-Cai Xing
Journal:  BMC Surg       Date:  2021-06-29       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.